For the year ending 2025-12-31, ADCT had $10,166K increase in cash & cash equivalents over the period. -$141,438K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -142,623 |
| Share-based compensation expense | 6,905 |
| Accretion expense of deferred royalty obligation | 29,132 |
| Cumulative catch-up adjustment, deferred royalty obligation | 22,212 |
| Write-downs of inventory | 2,284 |
| Depreciation | 705 |
| Amortization of operating lease right-of-use assets | 1,171 |
| Share of results in joint venture | 0 |
| Amortization of debt discount, senior secured term loan | 1,820 |
| Impairment of long-lived assets and prepaid expenses and other related costs | 6,695 |
| Other | -304 |
| Accounts receivable, net | 8,789 |
| Inventory | 2,381 |
| Prepaid expenses and other current assets | -5,233 |
| Other long-term assets | 46 |
| Accounts payable | -9,038 |
| Accrued expenses and other current liabilities | -7,420 |
| Operating lease liabilities | -2,504 |
| Other long-term liabilities | -410 |
| Net cash used in operating activities | -141,174 |
| Payment for purchases of property and equipment | 264 |
| Proceeds from the sale of equipment | -659 |
| Net cash provided by (used in) investing activities | 395 |
| Proceeds from sale of common shares, net of transaction costs | 86,282 |
| Proceeds from pre-funded warrants, net of transaction costs | 65,372 |
| Proceeds from share issuance under stock purchase plan | 271 |
| Proceeds from the exercise of options | 534 |
| Taxes paid related to net settled equity awards | 1,514 |
| Net cash provided by financing activities | 150,945 |
| Net decrease in cash and cash equivalents | 10,166 |
| Exchange (losses)/gains on cash and cash equivalents | 305 |
| Cash and cash equivalents at beginning of year | 250,867 |
| Cash and cash equivalents at end of year | 261,338 |
ADCT
ADCT